Efficacy and Safety of Octagam® in Patients With Chronic Inflammatory Demyelinating Polyneuropathy

Efficacy and Safety of Octagam® in Patients With Chronic Inflammatory Demyelinating Polyneuropathy

Abstract Introduction Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a debilitating autoimmune neuropathy that is treated with intravenous immunoglobulin (IVIG). The aim of this retrospective study was to investigate the efficacy and safety of the sucrose-free IVIG Octagam® (Oct...

Full description

Bibliographic Details
Main Authors: Chafké Belmokhtar, Pierre Lozeron, David Adams, Jérôme Franques, Arnaud Lacour, Etienne Godet, Mathieu Bataille, Odile Dubourg, Gilles Angibaud, Emilien Delmont, Françoise Bouhour, Philippe Corcia, Jean Pouget
Format: Article
Language:English
Published: Adis, Springer Healthcare 2019-03-01
Series:Neurology and Therapy
Subjects:
Chronic inflammatory demyelinating polyneuropathy
Immunoglobulins
Immunotherapy
Octagam®
Peripheral nervous system disease
Online Access:http://link.springer.com/article/10.1007/s40120-019-0132-5

Internet

http://link.springer.com/article/10.1007/s40120-019-0132-5

Similar Items